Magnetic resonance imaging |
Cancer cell lines (4T1, HepG2, and SKBR3) |
Gold–iron oxide nanoparticles |
Anti-miR-21. Phototherapy treatment. |
Bose, R.J.C., ACS Nano, 2018 [97] |
Magnetic resonance imaging |
MDA-MB-231 human breast cancer cells |
Superparamagnetic iron oxide nanoparticles |
Olaparib (PARP inhibitor) |
Jung, K.O., Biomaterials, 2018 [104] |
Magnetic resonance imaging |
Macrophage cells |
Iron oxide nanoparticles |
Chemotherapeutic agent (doxorubicin), tissue plasminogen activator (t-PA) and two photosensitizers |
Silva, A.K., Nanomedicine, 2015 [101] |
Magnetic resonance imaging |
Lung fibroblast cell |
Super paramagnetic iron oxide nanoparticle |
Anticancer drug (doxorubicin) |
Srivastava, A., Sci. Rep., 2016 [103] |
Magnetic resonance imaging |
Macrophage cell line Raw264.7 |
Superparamagnetic iron oxide nanoparticles |
Curcumin (Cur) and neuropilin-1-targeted peptide |
Jia, G., Biomaterials, 2018 [102] |